+ Follow BONE RESEARCH Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 369095
[Title] => Osteoporosis Treatment: Study assesses long-term efficacy of ibandronic acid
[Summary] =>
New findings from the first year of a study assessing the long-term efficacy of ibandronic acid, the first and only once-monthly bishophonate indicated for the treatment of osteoporosis in women, show that the drug "continues to be highly effective at strengthening bone in the spine and hip by increasing bone mineral density (BMD)."
The Monthly Oral iBandronate in Ladies Long Term Extension (MOBILE LTE) study also shows ibandronic acid as well tolerated over a three-year period.
[DatePublished] => 2006-11-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
BONE RESEARCH
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 369095
[Title] => Osteoporosis Treatment: Study assesses long-term efficacy of ibandronic acid
[Summary] =>
New findings from the first year of a study assessing the long-term efficacy of ibandronic acid, the first and only once-monthly bishophonate indicated for the treatment of osteoporosis in women, show that the drug "continues to be highly effective at strengthening bone in the spine and hip by increasing bone mineral density (BMD)."
The Monthly Oral iBandronate in Ladies Long Term Extension (MOBILE LTE) study also shows ibandronic acid as well tolerated over a three-year period.
[DatePublished] => 2006-11-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
November 16, 2006 - 12:00am